Atlas Trials

Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

Clinical trial NCT06157216 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06157216
Sponsor
Qilu Hospital of Shandong University
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Stage II-III Gastric Cancer
Start date
2023-10-01
Primary completion
2027-04-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.